Las Vegas, NV -- (SBWIRE) -- 01/04/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: LinnCo LLC(NASDAQ:LNCO), Globalstar, Inc.(OTCMKTS:GSAT), New Residential Investment Corp(NYSE:NRZ), Exelixis, Inc.(NASDAQ:EXEL)
LinnCo LLC(NASDAQ:LNCO) was a volume gainer of 1.79 million shares and the average volume of the stock remained 1.56 million shares. The stock opened the session at $30.75 and finished at the end of the day at $30.71 and the stock plunged -0.32%.The market capitalization of the stock remained 1.07 billion. Linn Co, LLC (Linn Co) sole purpose is to own LINN Energy, LLC (LINN) units. LINN is focused on the development and acquisition of oil and natural gas properties, which include various producing basins within the United States.
Has LNCO Found The Bottom And Ready To Gain Momentum? Find Out Here
In the preceding trading session, Globalstar, Inc.(OTCMKTS:GSAT) exchanged 1.78 million shares and the average volume remained 3.82 million shares. The stock closed the session at $1.72 with the drop of -1.71%. Globalstar, Inc. (Globalstar) is a provider of mobile voice and data communications services globally via satellite. Globalstar’s satellite communications business, by providing critical mobile communications to the Company's subscribers, serves principally recreation and personal; government.
Why Should Investors Buy GSAT After the Recent Fall? Just Go Here and Find Out
New Residential Investment Corp(NYSE:NRZ) decreased -0.30% and its closing price was $6.66. The volume of the stock was 1.78 million shares and the average volume remained 2.39 million shares. The market capitalization of the stock remained 1.69 billion. New Residential Investment Corp., incorporated on September 26, 2013, is a real estate investment trust. The Company focuses on investing in, and actively managing, investments related to residential real estate.
Will NRZ Get Buyers Even After The Recent Rally? Find Out Here
Exelixis, Inc.(NASDAQ:EXEL) exchanged 1.75 million shares in the previous trading session, and its average trading remained 1.35 million shares. EXEL advanced 0.82% and it closed the trading at $6.18. The market capitalization of the stock remained 1.14 billion. Exelixis, Inc. (Exelixis) is a biotechnology company engaged in developing small molecule therapies for the treatment of cancer. The Company is focusing its resources and development efforts on cabozantinib (XL184).
For How Long EXEL’s Gloss will Attract Investors? Find out via this report
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)